ANCA positivity is not associated with rheumatoid factor nor with Caplan´s syndrome in asbestos exposure Source: Eur Respir J 2004; 24: Suppl. 48, 146s Year: 2004
Place of anti-CCP antibodies in respiratory manifestations of rheumatoid disease Source: International Congress 2017 – Novel and old entities Year: 2017
Occurrence of ANCA positivity in persons with silicosis Source: Eur Respir J 2002; 20: Suppl. 38, 604s Year: 2002
False positive chlamydia pneumonia IgM assay induced by rheumatoid factor Source: Eur Respir J 2006; 28: Suppl. 50, 3s Year: 2006
ANCA positivity in persons with asbestos exposure Source: Eur Respir J 2003; 22: Suppl. 45, 185s Year: 2003
Antinuclear antibodies in interstitial lung diseases: Prevalence and predictive factors Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: mechanistic insights and prognostic markers Year: 2018
Nine cases of interstitial lung disease associated with anti-CADM140 antibody positive dermatomyositis Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012
Clinical implications of ANCA positivity in idiopathic pulmonary fibrosis patients Source: Breathe, 16 (1) 190321; 10.1183/20734735.0321-2019 Year: 2020
A major genetic determinant of autoimmune diseases is associated with the presence of autoantibodies in hypersensitivity pneumonitis Source: Eur Respir J, 56 (2) 1901380; 10.1183/13993003.01380-2019 Year: 2020
Interstitial lung disease associated with ANCA positivity: a retrospective analysis Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019
Carbamylation/citrullination of IgG Fc in bronchiectasis, established RA with bronchiectasis and RA smokers: a potential risk factor for disease Source: ERJ Open Res, 3 (3) 00018-2017; 10.1183/23120541.00018-2017 Year: 2017
The prognostic factors of cases with pulmonary involvement of rheumatoid arthritis at first discharge Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders Year: 2008
RA autoantibodies as predictors of rheumatoid arthritis in non-cystic fibrosis bronchiectasis patients Source: Eur Respir J 2014; 44: 1082-1085 Year: 2014
Silicosis, asbestosis and ANCA positivity Source: Eur Respir J 2001; 18: Suppl. 33, 437s Year: 2001
Differences between ANCA positive and negative lung fibrosis cases without vasculitis Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia Year: 2019
Risk factors of interstitial lung diseases in patients with rheumatoid arthritis. Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019
Are smoking and COPD associated with ILD onset in rheumatoid arthritis? Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020
Plethysmographic profile of patients with rheumatoid arthritis (RA): a comparative study between ACPA positive and negative patients Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020
Analysis of lung diseases associated with rheumatoid arthritis Source: Eur Respir J 2006; 28: Suppl. 50, 307s Year: 2006
Antinuclear autoantibodies (ANA) and C-reactive protein (CRP) in chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015